Heart failure guidelines implementation: Lifting barriers using registries and networks

por Keramida, Kalliopi, Filippatos, Gerasimos
Publicado en Anatol J Cardiol (2020)

Clinical development plan for regenerative therapy in heart failure

por Terzic, Andre, Behfar, Atta, Filippatos, Gerasimos
Publicado en Eur J Heart Fail (2016)

Cardio‐oncology services during the COVID‐19 pandemic: practical considerations and challenges

por Farmakis, Dimitrios, Keramida, Kalliopi, Filippatos, Gerasimos
Publicado en Eur J Heart Fail (2020)

Drug therapy for patients with systolic heart failure after the PARADIGM-HF trial: in need of a new paradigm of LCZ696 implementation in clinical practice

por Filippatos, Gerasimos, Farmakis, Dimitrios, Parissis, John, Lekakis, John
Publicado en BMC Med (2015)

Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice

por Butler, Javed, Zannad, Faiez, Filippatos, Gerasimos, Anker, Stefan D., Packer, Milton
Publicado en Eur Heart J (2020)

Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies

por Anker, Stefan D., Ponikowski, Piotr, Mitrovic, Veselin, Peacock, W. Frank, Filippatos, Gerasimos
Publicado en Eur Heart J (2015)

Pulmonary Oedema—Therapeutic Targets

por Chioncel, Ovidiu, Collins, Sean P, Ambrosy, Andrew P, Gheorghiade, Mihai, Filippatos, Gerasimos
Publicado en Card Fail Rev (2015)

Clinical effects of cardiac contractility modulation in heart failure with mildly reduced systolic function

por Tschöpe, Carsten, Butler, Javed, Farmakis, Dimitrios, Morley, Deborah, Rao, Ishu, Filippatos, Gerasimos
Publicado en ESC Heart Fail (2020)

Fas induces apoptosis in human coronary artery endothelial cells in vitro

por Filippatos, Gerasimos, Ang, Edmund, Gidea, Claudia, Dincer, Erhan, Wang, Rongqi, Uhal, Bruce D
Publicado 2004

Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched study

por Campbell, Ruth C., Sui, Xuemei, Filippatos, Gerasimos, Love, Thomas E., Wahle, Christy, Sanders, Paul W., Ahmed, Ali
Publicado 2009

Telephone based survey in adults with congenital heart disease during COVID-19 pandemic

por Frogoudaki, Alexandra A., Farmakis, Dimitrios, Tsounis, Dimitrios, Liori, Sotiria, Stamoulis, Konstadinos, Ikonomidis, Ignatios, Filippatos, Gerasimos, Parissis, John
Publicado en Cardiol J (2020)

Self-assessment of health status is associated with inflammatory activation and predicts long-term outcomes in chronic heart failure

por Parissis, John T., Nikolaou, Maria, Farmakis, Dimitrios, Paraskevaidis, Ioannis A., Bistola, Vassiliki, Venetsanou, Koula, Katsaras, Dimitrios, Filippatos, Gerasimos, Kremastinos, Dimitrios T.
Publicado 2009

Global Longitudinal Strain of the Systemic Ventricle Is Correlated with Plasma Galectin-3 and Predicts Major Cardiovascular Events in Adult Patients with Congenital Heart Disease

por Frogoudaki, Alexandra A., Pantelakis, Ioannis, Bistola, Vasiliki, Kroupis, Christos, Birba, Dionysia, Ikonomidis, Ignatios, Alexopoulos, Dimitrios, Filippatos, Gerasimos, Parissis, John
Publicado en Medicina (Kaunas) (2020)

Effect of Serum Insulin on the Association between Hyperuricemia and Incident Heart Failure

por Desai, Ravi V., Ahmed, Mustafa I., Fonarow, Gregg C., Filippatos, Gerasimos S., White, Michel, Aban, Inmaculada B., Aronow, Wilbert S., Ahmed, Ali
Publicado 2010

Patient factors associated with titration of medical therapy in patients with heart failure with reduced ejection fraction: data from the QUALIFY international registry

por Cowie, Martin R., Schöpe, Jakob, Wagenpfeil, Stefan, Tavazzi, Luigi, Böhm, Michael, Ponikowski, Piotr, Anker, Stefan D., Filippatos, Gerasimos S., Komajda, Michel
Publicado en ESC Heart Fail (2021)

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney dise...

por Pitt, Bertram, Kober, Lars, Ponikowski, Piotr, Gheorghiade, Mihai, Filippatos, Gerasimos, Krum, Henry, Nowack, Christina, Kolkhof, Peter, Kim, So-Young, Zannad, Faiez
Publicado 2013

Levosimendan vs. dobutamine: outcomes for acute heart failure patients on β-blockers in SURVIVE†

por Mebazaa, Alexandre, Nieminen, Markku S., Filippatos, Gerasimos S., Cleland, John G., Salon, Jeffrey E., Thakkar, Roopal, Padley, Robert J., Huang, Bidan, Cohen-Solal, Alain
Publicado 2009

Impact of 3 Common ABCA1 Gene Polymorphisms on Optimal vs Non-Optimal Lipid Profile in Greek Young Nurses

por Marvaki, Apostolia, Kolovou, Vana, Katsiki, Niki, Boutsikou, Maria, Kotanidou, Anastasia, Orfanos, Stylianos, Filippatos, Gerasimos, Marvaki, Katerina, Koumoulidis, Anastasios, Mavrogeni, Sophie, Kolovou, Genovefa
Publicado 2014

Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular‐only pacing

por Filippatos, Gerasimos, Birnie, David, Gold, Michael R., Gerritse, Bart, Hersi, Ahmad, Jacobs, Sandra, Kusano, Kengo, Leclercq, Christophe, Mullens, Wilfried, Wilkoff, Bruce L.
Publicado en Eur J Heart Fail (2017)

Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR‐HF substudy

por Okonko, Darlington O., Jouhra, Fadi, Abu‐Own, Huda, Filippatos, Gerasimos, Colet, Josep Comin, Suki, Chainey, Mori, Claudio, Ponikowski, Piotr, Anker, Stefan D.
Publicado en ESC Heart Fail (2019)